Connect Biopharma Holdings Ltd (CNTB): Total Liabilities

Annual figures by period end, from SEC filings.

$14.10M
As of 2025-12-31
$15.71M
As of 2026-09-30
$25.88M2023-12-31: $25.88M2024-12-31: $9.12M2025-12-31: $14.10M$14.10M
2023-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$14.10M+54.6%2026-03-31, Balance as of period end
2024-12-31$9.12M-64.8%2026-03-31, Balance as of period end
2023-12-31$25.88Mn/a2025-03-31, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$14.10M+54.6%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$50.21M+12.4%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$33.41M+88.8%
Silo Pharma, Inc. (SILO)2025-12-31$1.30M-45.3%
HCW Biologics Inc. (HCWB)2025-12-31$21.76M-41.2%
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31$43.94M-0.5%
Altimmune, Inc. (ALT)2025-12-31$55.04M+248.4%
iBio, Inc. (IBIO)2026-06-30$13.40M+61.3%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$20.33M+127.9%

Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗